ISRCTN43811467
12 evidence topics · 2 sources
Objective
Treatment objective
Location and study date
Study design
Trial masking and control
Eligibility criteria
Tuberculosis population
Treatment
Regimen
| Characteristic | Quoted value |
|---|---|
| Treatment course | “25 days” |
| Concomitant intervention | “brief behavioural support” |
Study outcomes
Rationale for using continuous smoking abstinence as the primary endpoint
Primary assessment
| Characteristic | Quoted value |
|---|---|
| Continuous-abstinence follow-up, months | “6” |
Statistical analysis description
Number of participants (Planned and analyzed)
Description of analysis sets
Primary analysis population
Results
Participant disposition
No evidence found.
Baseline characteristics
No evidence found.
Efficacy results
Health-related quality of life and patient-reported outcomes
No evidence found.
Safety results
Study limitations
Summary
The study population had pulmonary tuberculosis, and both groups received brief behavioral support. The investigators did not support adding cytisine in this setting. Results should not be treated as a direct evaluation of the ORCA regimen in the general smoking population.